Delivery Order SPE2DB20D3103-SPE2DB21FL4P0
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,568.86 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch based in Philadelphia, Pennsylvania. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a prime vendor pharmaceutical supply service for the DLA Troop Support Medical. The contract, valued at $1,646.14, is a Firm Fixed Price delivery order that runs through August 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $2,591.70, is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Prime Vendor Pharmacy Branch in Philadelphia. The $2,484.99 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which runs through November 2026. This IDC allows the DLA to efficiently procure a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,333.73, is a Firm Fixed Price Delivery Order for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.55 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of July 28, 2021. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,116.60 firm-fixed-price delivery order supports the Prime Vendor Pharmacy Branch-Philadelphia program. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,099.76 Firm Fixed Price delivery order is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of December 1, 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order valued at $2,373.00. The contract is for the provision of pharmaceutical products and medical supplies to support DLA Troop Support Medical's programs, including military treatment facilities and veterans' healthcare services. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a Prime Vendor Pharmaceutical Branch in Philadelphia. The $4,037.60 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which runs through November 2026. This IDC enables efficient...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FL4P0Delivery Order
This federal contract award, with the ID SPE2DB20D3103|SPE2DB21FL4P0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,636.75, is a delivery order for a prime vendor pharmaceutical contract for the DLA Troop Support Medical in Philadelphia, PA. The contract is a Firm Fixed Price (FFP) arrangement and is not designated with any set-aside requirements. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/3/20 |